NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Get Started
$12.55 +0.01 (+0.08 %)
(As of 06/20/2018 11:13 AM ET)
Previous Close$12.54
Today's Range$12.47 - $12.60
52-Week Range$10.78 - $16.13
Volume18,570 shs
Average Volume1.52 million shs
Market Capitalization$2.22 billion
P/E Ratio26.60
Dividend YieldN/A
Beta1.26
Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company's Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDRX
CUSIP01988P10
Webwww.allscripts.com
Phone312-506-1200

Debt

Debt-to-Equity Ratio1.53
Current Ratio1.02
Quick Ratio1.02

Price-To-Earnings

Trailing P/E Ratio26.60
Forward P/E Ratio22.82
P/E Growth1.66

Sales & Book Value

Annual Sales$1.81 billion
Price / Sales1.24
Cash Flow$1.6937 per share
Price / Cash7.41
Book Value$6.42 per share
Price / Book1.95

Profitability

EPS (Most Recent Fiscal Year)$0.47
Net Income$-152,600,000.00
Net Margins-11.34%
Return on Equity7.80%
Return on Assets2.20%

Miscellaneous

Employees8,900
Outstanding Shares177,950,000

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) issued its quarterly earnings results on Thursday, May, 3rd. The software maker reported $0.16 EPS for the quarter, missing the Zacks' consensus estimate of $0.17 by $0.01. The software maker had revenue of $518.60 million for the quarter, compared to the consensus estimate of $527.34 million. Allscripts Healthcare Solutions had a positive return on equity of 7.80% and a negative net margin of 11.34%. The business's revenue was up 24.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.13 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.19 billion.

What price target have analysts set for MDRX?

16 brokers have issued 1-year target prices for Allscripts Healthcare Solutions' shares. Their predictions range from $12.00 to $19.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $16.3420 in the next twelve months. View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on MDRX shares. The stock offers 43% upside potential to our 12-month price target of $18. We continue to believe that Allscripts’ growth outlook has improved after a series of strategic acquisitions. The acquisitions of McKesson’s EIS business and Practice Fusion added a significant amount of recurring revenue. With its 1Q18 release, the company announced the acquisition of privately-held HealthGrid, a provider of patient engagement tools to providers. Finally, at a recent competitor conference, the company indicated it has been pretty active" in stock repurchases in 2Q18, after repurchasing $50 million in 1Q18." (6/8/2018)
  • 2. Maxim Group analysts commented, "1Q18 bookings of $304M, up 6.3% y/y, was below our estimate of $315M, but relatively inline with consensus of $305M." (5/4/2018)
  • 3. According to Zacks Investment Research, "Allscripts has had a favorable run on the bourses over the last year, trading above the broader industry. The company’s solid growth in U.S. Core Solutions and Services holds promise at the moment. Allscripts Sunrise electronic health record (EHR) platform and Revenue Cycle Management Services are likely to drive the company’s top line in the quarters to come. Also, Allscripts has a leading market share in inpatient and ambulatory settings. Allscripts announced a definitive agreement to buy Practice Fusion for $100 million in cash. However, the company’s continued reliance on mergers and acquisition activities poses substantial integration risks. Intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. Allscripts also expects a modest increase in operating expenses to support business growth over the long haul." (1/25/2018)

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a decline in short interest in the month of May. As of May 15th, there was short interest totalling 14,902,389 shares, a decline of 9.3% from the April 30th total of 16,428,172 shares. Based on an average daily trading volume, of 3,032,726 shares, the short-interest ratio is presently 4.9 days. Approximately 8.5% of the shares of the company are short sold.

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 60)
  • Mr. Richard J. Poulton, Pres (Age 53)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 55)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 51)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

News stories about MDRX stock have trended positive on Wednesday, Accern Sentiment reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a news impact score of 0.33 on Accern's scale. They also assigned news coverage about the software maker an impact score of 46.64 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by many different of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (5.66%), Iridian Asset Management LLC CT (4.02%), Fiduciary Management Inc. WI (3.92%), Fisher Asset Management LLC (2.92%), Silvercrest Asset Management Group LLC (2.49%) and Neuberger Berman Group LLC (1.79%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Michael Klayko, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Dalton Greiner Hartman Maher & Co., Mesirow Financial Investment Management Equity Management, Monarch Partners Asset Management LLC, Sei Investments Co., Blue Harbour Group L.P., Victory Capital Management Inc. and Hsbc Holdings PLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Which institutional investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Silvercrest Asset Management Group LLC, Fort Washington Investment Advisors Inc. OH, UBS Group AG, Federated Investors Inc. PA, Fiduciary Management Inc. WI, Wesbanco Bank Inc. and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $12.55.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.22 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  490 (Vote Outperform)
Underperform Votes:  479 (Vote Underperform)
Total Votes:  969
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.